Chemoprevention of head and neck cancer with aspirin - A case-control study

被引:48
作者
Jayaprakash, Vijayvel
Rigual, Nestor R.
Moysich, Kirsten B.
Loree, Thom R.
Nasca, Maureen A. Sullivan
Menezes, Ravi J.
Reid, Mary E.
机构
[1] Roswell Pk Canc Inst, Div Canc Prevent, Dept Epidemiol, Buffalo, NY 14263 USA
[2] Roswell Park Canc Inst, Dept Epidemiol, Buffalo, NY USA
[3] Roswell Park Canc Inst, Div Canc Prevent & Populat Sci, Buffalo, NY USA
[4] Roswell Park Canc Inst, Dept Head & Neck Plast Surg, Buffalo, NY USA
[5] Roswell Park Canc Inst, Dept Dent & Maxillofacial Prosthet, Buffalo, NY USA
关键词
D O I
10.1001/archotol.132.11.1231
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To evaluate the chemopreventive potential of aspirin against head and neck cancer. Design: Hospital-based case-control study Setting: National Cancer Institute-designated comprehensive cancer center. Patients: Individuals who received medical services at the Roswell Park Cancer Institute, Buffalo, NY, between 1982 and 1998 and who completed a comprehensive epidemiologic questionnaire. Main Outcome Measure: Aspirin use among 529 patients with head and neck cancer and 529 hospital-based control subjects matched by age, sex, and smoking status. Results: Aspirin use was associated with a 25% reduction in the risk of head and neck cancer (adjusted odds ratio, 0.75; 95% confidence interval, 0.58-0.96). Consistent risk reductions were also noted in association with frequent and prolonged aspirin use. Further, a consistently decreasing trend in risk was noted with increasing duration of aspirin use (P-trend=.005). Risk reduction was observed across all 5 primary tumor sites, with cancers of the oral cavity and oropharynx exhibiting greater risk reduction. When analyzed by smoking and alcohol exposure levels, participants moderately exposed to either showed a statistically significant 33% risk reduction (adjusted odds ratio, 0.67; 95% confidence interval, 0.50-0.91), whereas participants exposed to both heavy smoking and alcohol use did not benefit from the protective effect of aspirin. The reduction in risk was relatively more significant in women. Conclusions: Aspirin use is associated with reduced risk of head and neck cancer. This effect is more pronounced in individuals with low to moderate exposure to cigarette smoke or alcohol consumption.
引用
收藏
页码:1231 / 1236
页数:6
相关论文
共 24 条
[1]  
BLOT WJ, 1988, CANCER RES, V48, P3282
[2]   Aspirin use and cancers of the upper aerodigestive tract [J].
Bosetti, C ;
Talamini, R ;
Franceschi, S ;
Negri, E ;
Garavello, W ;
La Vecchia, C .
BRITISH JOURNAL OF CANCER, 2003, 88 (05) :672-674
[3]  
Chan G, 1999, CANCER RES, V59, P991
[4]   RACIAL-DIFFERENCES IN RISK OF ORAL AND PHARYNGEAL CANCER - ALCOHOL, TOBACCO, AND OTHER DETERMINANTS [J].
DAY, GL ;
BLOT, WJ ;
AUSTIN, DF ;
BERNSTEIN, L ;
GREENBERG, RS ;
PRESTONMARTIN, S ;
SCHOENBERG, JB ;
WINN, DM ;
MCLAUGHLIN, JK ;
FRAUMENI, JF .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (06) :465-473
[5]   RECENT CANCER TRENDS IN THE UNITED-STATES [J].
DEVESA, SS ;
BLOT, WJ ;
STONE, BJ ;
MILLER, BA ;
TARONE, RE ;
FRAUMENI, JF .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (03) :175-182
[6]   Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum:: a meta-analysis -: art. no. 28 [J].
González-Pérez, A ;
Rodríguez, LAG ;
López-Ridaura, R .
BMC CANCER, 2003, 3 (1)
[7]  
Harris RE, 2005, ONCOL REP, V13, P559
[8]  
Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]
[9]   Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer [J].
Hwang, D ;
Scollard, D ;
Byrne, J ;
Levine, E .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (06) :455-460
[10]   Cancer statistics, 2005 [J].
Jemal, A ;
Murray, T ;
Ward, E ;
Samuels, A ;
Tiwari, RC ;
Ghafoor, A ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30